20/20 Biolabs Inc

NAS:AIDXHealthcarenasdaq_composite

——At close · Market cap — · Next earnings Wed 2 Dec

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Net income	(0.0)	0.0	0.0	(0.0)	(0.0)	(3.7)	−67245.9%
Depreciation & amortization	0.0	0.0	0.0	0.0	0.0	0.0	−100.0%
Stock-based compensation	0.0	0.0	0.0	0.0	0.0	0.0	—
Change in working capital	(0.0)	(0.0)	0.0	0.0	0.0	0.0	−100.0%
Operating cash flow	(0.0)	(0.0)	0.0	(0.0)	(0.0)	(1.9)	−73769.9%
Capital expenditure	(0.0)	(0.0)	(0.0)	(0.0)	0.0	0.0	−100.0%
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0	—
Investing cash flow	0.0	(0.0)	(0.0)	(0.0)	0.0	0.0	—
Dividends paid	0.0	0.0	0.0	0.0	0.0	0.0	—
Share buybacks	0.0	0.0	0.0	0.0	0.0	0.0	—
Debt issued / repaid	0.0	(0.0)	0.0	(0.0)	0.0	0.0	—
Financing cash flow	0.0	0.0	0.0	(0.0)	0.0	1.2	+395933.9%
Free cash flow	(0.0)	(0.0)	0.0	(0.0)	(0.0)	(1.9)	−73770.0%
Net change in cash	0.0	(0.0)	0.0	(0.0)	(0.0)	(0.8)	−32779.5%

USD billionsUpdated Mon 17 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.